5-fluorouracil,oxaliplatin,Irinotecan
Not Tagged
[]
 norpact-1 the primary endpoint was os. 140 patients were randomly assigned to neoadjuvant chemotherapy or upfront surgery in resectable #pdac. median os
25.1 months with neoadjuvant folfirinox 38.5 months with upfront surgery with adj ffx (p=0.096) #asco2023 #pdac 
GI medical oncologist @DanaFarber | @MayoMN_IMRES | @MUMedicine | Tweets my own. Interests: Translational Onc, GI cancers